Loss of Asthma Control in Inner City Children with Asthma after Withdraw of Asthma Controller Medication

REFERENCES

• Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention ( updated 2008). URL: http://www.ginasthma.org; 2008.
   Google Scholar
• National Institutes of Health. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert panel report 2: Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; 1997. NIH publication 97--4051.
   Google Scholar
• National Institutes of Health, National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert panel report; Guidelines for the diagnosis and management of asthma, update on selected topics-2002. J Allergy Clin Immunol 2002; 110(5 suppl):S141–219.
   Google Scholar
• National Institutes of Health, National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert panel report 3 (EPR 3); Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(5 suppl):S94–138.
   Google Scholar
• Bahçeciler NN, Barlan IB, Nuhoglu Y, Basaran MM. Which factors predict success after discontinuation of inhaled budesonide therapy in children with asthma? J Asthma 2002; 39:37–46.
   PubMed Web of Science ®Google Scholar
• Fonseca MT, Camargos PA, Lasmar LM, Colosimo E, Fonseca MM. Risk factors associated with occurrence of clinical deterioration after cessation of beclomethasone in asthmatic children and adolescents. J Asthma 2005; 42:479–485.
   Google Scholar
• Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005; 115:720–727.
   PubMed Web of Science ®Google Scholar
• Perrera BJ. Successful withdrawal of inhaled corticosteroids in childhood asthma. Respirology 2005; 10:385–388.
   Google Scholar
• Haahtela T, Jarvinen M, Kava T, Kirviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331:700–705.
   PubMed Web of Science ®Google Scholar
• Lönnkvist K, Hellman C, Lundahl J, Halldèn G, Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: Impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 2001; 107:812–817.
   PubMed Web of Science ®Google Scholar
• Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, Adcock IM, Barnes PJ. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. Chest 2007; 132:98–105.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Bacci E, Dente FL, Bartoli ML, Cianchetti S, Di Franco A, Vagaggini B, Zingoni M, Paggiaro PL. Predictors of symptom recurrence after low-dose inhaled corticosteroid cessation in mild persistent asthma. Respir Med 2006; 100:622–629.
   Google Scholar
• Tsurikisawa N, Tsuburai T, Oshikata C, Ono E, Saito H, Mitomi H, Akiyama K. Prognosis of adult asthma after normalization of bronchial hyperresponsiveness by inhaled corticosteroid therapy. J Asthma 2008; 45:445–451.
   Web of Science ®Google Scholar
• The Childhood Asthma Management Program Research Group. Longterm effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054–1063.
   PubMed Web of Science ®Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF, Strunk RC, Allen DB, Bloomberg GR, Heldt G, Krawiec M, Larsen G, Liu AH, Chinchilli VM, Sorkness CA, Taussig LM, Martinez FD. Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma. N Engl J Med 2006; 354:1985–1997.
   PubMed Web of Science ®Google Scholar
• Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A. Fluticasone propionate aerosol: Efficacy in patients with mild to moderate asthma. J Fam Pract 1996; 42:369–375.
   PubMedGoogle Scholar
• Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 2008; 122:662–668.
   PubMed Web of Science ®Google Scholar
• Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, Hartert TV. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008; 178:1123–1119.
   PubMed Web of Science ®Google Scholar
• Stensballe LG, Simonsen JB, Thomsen SF, Larsen AM, Lysdal SH, Aaby P, Kyvik KO, Skytthe A, Backer V, Bisgaard H. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 2009; 123:131–137.
   PubMed Web of Science ®Google Scholar
• Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RF Jr, Sorkness CA, Bloomberg GR, Morgan WJ, Paul IM, Guilbert T, Krawiec M, Covar R, Larsen G, Mellon M, Moss MH, Chinchilli VM, Taussig LM, Strunk RC; CARE Network. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008; 122:1127.
   PubMed Web of Science ®Google Scholar
• Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171:1077–1082.
   PubMed Web of Science ®Google Scholar